日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A mild and atom-efficient four-component cascade strategy for the construction of biologically relevant 4-hydroxyquinolin-2(1H)-one derivatives

一种温和且原子经济的四组分级联策略,用于构建具有生物学意义的4-羟基喹啉-2(1H)-酮衍生物

Grishin, Dmitrii A; Sharkovskaia, Kseniia I; Kolmakov, Ilya G; Ipatova, Daria A; Petrov, Rostislav A; Dagaev, Nikolai D; Skvortsov, Dmitry A; Khrenova, Maria G; Andreychev, Valeriy V; Evteev, Sergei A; Ivanenkov, Yan A; Antipin, Roman L; Dontsova, Olga А; Beloglazkina, Elena K

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

小分子 TNIK 抑制剂针对临床前和临床模型中的纤维化

Feng Ren, Alex Aliper, Jian Chen, Heng Zhao, Sujata Rao, Christoph Kuppe, Ivan V Ozerov, Man Zhang, Klaus Witte, Chris Kruse, Vladimir Aladinskiy, Yan Ivanenkov, Daniil Polykovskiy, Yanyun Fu, Eugene Babin, Junwen Qiao, Xing Liang, Zhenzhen Mou, Hui Wang, Frank W Pun, Pedro Torres-Ayuso, Alexander V

A novel, covalent broad-spectrum inhibitor targeting human coronavirus M(pro).

一种新型的、针对人类冠状病毒 M(pro) 的共价广谱抑制剂

Sun Jing, Sun Deheng, Yang Qi, Wang Dong, Peng Jingjing, Guo Hu, Ding Xiaoyu, Chen Zhao, Yuan Bin, Ivanenkov Yan A, Yuan Jinwei, Zagribelnyy Bogdan A, He Yiyun, Su Jingyi, Wang Ling, Tang Jielin, Li Zhun, Li Rong, Li Taotao, Hu Xiaoyu, Liang Xing, Zhu Airu, Wei Peilan, Fan Yaya, Liu Sang, Zheng Jie, Guan Xin, Aliper Alex, Yang Minglei, Bezrukov Dmitry S, Xie Zhanhong, Terentiev Victor A, Peng Guilin, Polykovskiy Daniil A, Malyshev Alexander S, Malkov Maxim N, Zhu Qingsong, Aspuru-Guzik Alán, Ding Xiao, Cai Xin, Zhang Man, Zhao Jingxian, Zhong Nanshan, Ren Feng, Chen Xinwen, Zhavoronkov Alex, Zhao Jincun

α6GABAA RECEPTOR-SELECTIVE POSITIVE ALLOSTERIC MODULATOR AS A NOVEL THERAPY FOR ADHD: A PRECLINICAL STUDY IN MK-801- TREATED JUVENILE MICE

α6GABAA受体选择性正向变构调节剂作为ADHD的新型疗法:MK-801治疗的幼鼠的临床前研究

Ivanenkov, Vasily V; Sévigny, Jean; Kirley, Terence L; Chiou, *Lih-Chu; Lu, Chia-Chi; Lee, Hsin-Jung; Mouri, Akihiro; Sharmin, Dishary; Cook, James; Nabeshima, Toshitaka

New Kinase Inhibitors That Are Selectively Cytotoxic for Tumor Cells

对肿瘤细胞具有选择性细胞毒性的新型激酶抑制剂

Skvortsov, D A; Zhirkina, I V; Ipatova, D A; Pisarev, A R; Malyshev, A S; Ivanenkov, Y A; Kartsev, V G; Dontsova, O A

Quantum-assisted fragment-based automated structure generator (QFASG) for small molecule design: an in vitro study

量子辅助的基于片段的自动结构生成器(QFASG)用于小分子设计:一项体外研究

Evteev, Sergei; Ivanenkov, Yan; Semenov, Ivan; Malkov, Maxim; Mazaleva, Olga; Bodunov, Artem; Bezrukov, Dmitry; Sidorenko, Denis; Terentiev, Victor; Malyshev, Alex; Zagribelnyy, Bogdan; Korzhenevskaya, Anastasia; Aliper, Alex; Zhavoronkov, Alex

Chemistry42: An AI-Driven Platform for Molecular Design and Optimization

Chemistry42:一个基于人工智能的分子设计与优化平台

Ivanenkov, Yan A; Polykovskiy, Daniil; Bezrukov, Dmitry; Zagribelnyy, Bogdan; Aladinskiy, Vladimir; Kamya, Petrina; Aliper, Alex; Ren, Feng; Zhavoronkov, Alex

Synthesis and Biological Evaluation of Novel Dispiro-Indolinones with Anticancer Activity

新型二螺吲哚啉酮的合成及抗癌活性生物学评价

Ivanenkov, Yan A; Kukushkin, Maxim E; Beloglazkina, Anastasia A; Shafikov, Radik R; Barashkin, Alexander A; Ayginin, Andrey A; Serebryakova, Marina S; Majouga, Alexander G; Skvortsov, Dmitry A; Tafeenko, Viktor A; Beloglazkina, Elena K

Nybomycin inhibits both types of E. coli DNA gyrase - fluoroquinolone-sensitive and fluoroquinolone-resistant

尼博霉素可抑制两种类型的大肠杆菌 DNA 旋转酶 - 氟喹诺酮敏感型和氟喹诺酮耐药型

Dmitrii I Shiriaev, Alina A Sofronova, Ekaterina A Berdnikovich, Dmitrii A Lukianov, Ekaterina S Komarova, Valeria I Marina, Yuliya V Zakalyukina, Mikhail V Biryukov, Tinashe P Maviza, Yan A Ivanenkov, Petr V Sergiev, Ilya A Osterman, Olga A Dontsova

Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses

研究性神经氨酸酶抑制剂AV5080在甲型和乙型流感病毒中的耐药性谱

Ivashchenko, Andrei A; Jones, Jeremy C; Shkil, Dmitry O; Ivanenkov, Yan A; Pascua, Philippe Noriel Q; Penaflor, Melissa K; Karapetian, Ruben N; Govorkova, Elena A; Ivachtchenko, Alexandre V